ON2 Assessing the Performance of Landmark Response Analysis to Improve Overall Survival Extrapolation in Nivolumab NSCLC TrialsM.A. Chaudhary,S. Rafiq,M.K. Siddiqui, J. Vanderpuye-Orgle, M. Edmonson-Jones, S. Teitsson,A. Juarez-Garcia, J.R. PenrodValue in Health(2020)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要